BackShanghai Haohai Biological Technology , Ltd. Overview

Shanghai Haohai Biological Technology , Ltd. Goodwill

Latest goodwill for 688366.SS: $270M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$268.35M
↓ 36.87% YoYΔ $-156.70M vs prior year quarter

Peer trimmed avg / median

Loading

Shanghai Haohai Biological Technology , Ltd. Goodwill History

Loading

Shanghai Haohai Biological Technology , Ltd. vs. peers: Goodwill Comparison

Loading

Shanghai Haohai Biological Technology , Ltd. Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Shanghai Haohai Biological Technology , Ltd. (688366.SS) FAQ

As of the most recent data (June 2026), 688366.SS shows a goodwill of $270M. That compares with $430M in the prior-year period — down 36.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 688366.SS's goodwill is now $270M (was $430M) — a 36.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shanghai Haohai Biological Technology , Ltd. is outperforming or lagging.

Tracking 688366.SS's goodwill over time shows whether Shanghai Haohai Biological Technology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $270M That compares with $430M in the prior-year period — down 36.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Shanghai Haohai Biological Technology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $270M) with ownership activity and broader fundamentals.

Shanghai Haohai Biological Technology , Ltd.'s goodwill is $270M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.